Cuprina Holdings Ltd. logo

Cuprina Holdings Ltd. (CUPR)

Market Closed
16 Jun, 20:00
NASDAQ (CM) NASDAQ (CM)
$
5. 27
-3.14
-37.3365%
After Hours
$
5. 25
-0.02 -0.3795%
6.06M Market Cap
- P/E Ratio
- Div Yield
964,373 Volume
- Eps
$ 8.41
Previous Close
Investors:
Add Transaction
Day Range
5.08 6.79
Year Range
1.76 76
Want to track CUPR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CUPR closed today lower at $5.27, a decrease of -37.3365% from yesterday's close, completing a monthly increase of 114.2276% or $2.81. Over the past 12 months, CUPR stock gained 1,258.2474%.
CUPR is not paying dividends to its shareholders.
Cuprina Holdings Ltd. has completed 1 stock splits, with the recent split occurring on May 27, 2026.
The company's stock is traded on one exchange.

CUPR Chart

People also search for

Lantern Pharma Inc.
$ 3.91
+5.9621%
Kalaris Therapeutics, Inc.
$ 9.81
+4.1401%
Mereo BioPharma Group plc - ADR
$ 0.29
-1.3514%
Veru Inc.
$ 3.13
0%
PolyPid Ltd.
$ 4.66
-0.1072%

Cuprina Holdings Ltd. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Gillian Curran
Gillian Curran Prospect Financial Group LLC
1,914.62 $6,128.71 $10,530.44 $4,401.73 71.82%

Cuprina Holdings Ltd. (CUPR) FAQ

What is the stock price today?

The current price is $5.27.

On which exchange is it traded?

Cuprina Holdings Ltd. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is CUPR.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 6.06M.

Has Cuprina Holdings Ltd. ever had a stock split?

Cuprina Holdings Ltd. had 1 splits and the recent split was on May 27, 2026.

Cuprina Holdings Ltd. Profile

Biotechnology Industry
Healthcare Sector
Yong Qi Quek CEO
NASDAQ (CM) Exchange
G2592E102 CUSIP
SG Country
15 Employees
- Last Dividend
27 May 2026 Last Split
- IPO Date

Overview

Cuprina Holdings (Cayman) Limited is a biomedical and biotechnology company based in Singapore, focused on innovating products designed to manage chronic wounds effectively. The company is at the forefront of the biomedical industry, committed to the research, development, and commercialization of cutting-edge solutions. Cuprina manufactures and distributes medical-grade sterile blowfly larvae bio-dressing products under the acclaimed MEDIFLY brand. These bio-dressing products are recognized as an effective biological debridement tool aimed at enhancing the healing of chronic wounds. Beyond its primary focus on wound care, Cuprina also explores opportunities in the health and beauty sectors, offering a diverse range of cosmeceutical products that aim to support overall health and aesthetic improvement.

Products and Services

  • MEDIFLY Bio-Dressing Products

    The flagship products of Cuprina Holdings, MEDIFLY bio-dressing items utilize sterile blowfly larvae as a natural biological debridement tool. These products are specifically designed for effective wound care, promoting healing by facilitating the removal of necrotic tissue and reducing infection risks. The bio-dressing provides a moist wound environment, which is crucial for speeding up the healing process in chronic wounds.

  • Cosmeceutical Products

    Cuprina's venture into the health and beauty sectors is marked by its range of cosmeceutical products. These products blend cosmetic and pharmaceutical benefits to provide effective solutions for skin health and beauty. The formulations may include active ingredients aimed at delivering targeted results, such as anti-aging, hydration, and skin rejuvenation, addressing various skin concerns while enhancing overall appearance.

Contact Information

Address: Blk 1090 Lower Delta Road #06-08
Phone: 65 8512 7275